Artificial Intelligence

San Jose, CA, 20th August 2019 -- OptraSCAN®, the leading end-to-end digital pathology solution provider today announced that U.S. Patent and Trademark Office (USPTO) has granted a patent to OptraSCAN’s invention, titled ‘Method of...

SALT LAKE CITY, August 19, 2019—ARUP Laboratories (ARUP), a national reference laboratory and worldwide leader in innovative laboratory research and development, and Techcyte, a leading developer of artificial intelligence (AI) based image...

Dr. Singh’s extensive experience in medical technologies will help grow the company’s AI-based solutions footprint in pathology labs Tel Aviv, Israel - Ibex Medical Analytics, the pioneer in artificial intelligence (AI)-based cancer...

It is an exciting time in the world of digital pathology, with the global market value projected to reach $7,561.1 million by 2022. Currently, industry experts are evaluating the early performance of the first FDA-approved platform. While...

By: Darrell Etherington MIT’s Computer Science and Artificial Intelligence Lab has developed a new deep learning-based AI prediction model that can anticipate the development of breast cancer up to five years in advance. Researchers...

News Update VIDEO: IBEX'S VISION FOR THE FUTURE OF CANCER DIAGNOSTICS Watch our Co-Founder and CEO, Joseph Mossel, discuss the challenges pathologists are facing and how Ibex Medical Analytics makes cancer diagnosis more efficient and...